Hillsdale Investment Management Inc. Amneal Pharmaceuticals, Inc. Transaction History

Hillsdale Investment Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$5.24 - $6.34 $603,124 - $729,734	115,100 Added 19.69%	699,719 $4.24 Million
Q4 2023 Feb 09, 2024	BUY	$3.36 - $6.21 $1.82 Million - $3.36 Million	541,000 Added 1240.29%	584,619 $3.55 Million
Q3 2023 Nov 09, 2023	BUY	$2.76 - $4.59 $120,388 - $200,211	43,619 New	43,619 $184,000
Q1 2022 Apr 28, 2022	SELL	$3.9 - $4.89 $31,980 - $40,098	-8,200 Reduced 0.94%	861,716 $3.59 Million
Q4 2021 Feb 07, 2022	SELL	$3.95 - $5.85 $10,270 - $15,209	-2,600 Reduced 0.3%	869,916 $4.17 Million
Q3 2021 Oct 21, 2021	BUY	$4.31 - $5.64 $369,366 - $483,348	85,700 Added 10.89%	872,516 $4.66 Million
Q2 2021 Jul 29, 2021	BUY	$5.12 - $6.82 $899,153 - $1.2 Million	175,616 Added 28.73%	786,816 $4.03 Million
Q1 2021 Apr 22, 2021	BUY	$4.74 - $7.38 $2.9 Million - $4.51 Million	611,200 New	611,200 $4.11 Million

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.